All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

Liraglutide 0.6mg: Weight Loss Average

Average weight loss on liraglutide 0.6mg. Covers realistic expectations at the starting dose, why significant weight loss does not occur at this level,...

By FormBlends Editorial Research|Source reviewed by FormBlends Medical Team||

Source Reviewed

Written by FormBlends Editorial Research · Checked against primary sources by FormBlends Medical Team

Liraglutide 0.6mg: Weight Loss Average custom 2026 header image for GLP-1 Weight Loss
Custom header image for Liraglutide 0.6mg: Weight Loss Average, GLP-1 Weight Loss, and better treatment decision-making.
In This Article

This article is part of our GLP-1 Weight Loss collection. See also: Provider Comparisons | Peptide Guides

Search and AI answer brief

Practical answer: Liraglutide 0.6mg: Weight Loss Average

Average weight loss on liraglutide 0.6mg. Covers realistic expectations at the starting dose, why significant weight loss does not occur at this level,...

Short answer

Average weight loss on liraglutide 0.6mg. Covers realistic expectations at the starting dose, why significant weight loss does not occur at this level,...

Search intent

This page answers a specific GLP-1 Weight Loss question rather than a generic overview.

What to verify

semaglutide, tirzepatide, retatrutide, safety and contraindications

How to use it

Use this information to prepare sharper questions for a licensed provider.

Key Takeaway

Average weight loss on liraglutide 0.6mg. Covers realistic expectations at the starting dose, why significant weight loss doesn't occur at this level, and what to expect as you titrate up.

Average weight loss on liraglutide 0.6mg during the first week of treatment is 0 to 2 pounds. This isn't clinically significant weight loss, and it isn't expected to be. The 0.6mg dose is an introductory titration step, not a therapeutic dose for weight management. Any weight change at this level reflects reduced food volume and water fluctuations rather than meaningful fat loss. The real weight loss begins as you titrate upward toward the 3.0mg target dose.

Why Weight Loss Is Minimal at 0.6mg

Liraglutide works by activating GLP-1 receptors in the brain and gut, reducing appetite and slowing digestion. At 0.6mg, the level of receptor activation is low enough that the weight loss effect is barely detectable:

  • The therapeutic dose for weight management (Saxenda) is 3.0mg daily, five times the starting dose
  • Even the diabetes dose (Victoza) uses 1.2mg to 1.8mg, which is two to three times the starting dose
  • At 0.6mg, the appetite-reducing signal is present but weak. Most patients still feel hungry at meal times.
  • The gastric-slowing effect is minimal, so food moves through your system at near-normal speed

Think of 0.6mg as the warm-up lap before the race. The effort isn't wasted, but the results come later.

What the Scale Shows During Week 1

Based on clinical data and prescriber experience, the first week at 0.6mg typically produces:

GLP-1 Weight Loss Results by Medication Mean Body Weight Loss (%) 0 6 12 18 24 22 15 8 24 Tirzepatide Semaglutide Liraglutide Retatrutide Based on published STEP and SURMOUNT trial data
GLP-1 Weight Loss Results by Medication. Based on published STEP and SURMOUNT trial data.
View data table
Bar chart showing glp-1 weight loss results by medication: Tirzepatide (22), Semaglutide (15), Liraglutide (8), Retatrutide (24)
CategoryMean Body Weight Loss (%)Detail
Tirzepatide22~22% body weight at 72 wks
Semaglutide15~15% body weight at 68 wks
Liraglutide8~8% body weight at 56 wks
Retatrutide24~24% in Phase 2 trial
Illustration for Liraglutide 0.6mg: Weight Loss Average
Scenario Approximate Weight Change Frequency
No change 0 lbs ~40% of patients
Mild loss -1 to -2 lbs ~45% of patients
Slight gain +1 to +2 lbs ~15% of patients

A slight gain isn't a bad sign. Normal weight fluctuations (water, sodium, menstrual cycle, bowel content) easily account for 1 to 2 pounds in either direction. This has nothing to do with the medication's effectiveness.

Putting 0.6mg in Context: The Full Treatment Picture

The real weight loss numbers come from the full-dose treatment period. Here is the trajectory patients can expect as they titrate:

Check your GLP-1 eligibility

Use our free BMI Calculator to see if you may qualify for provider-reviewed GLP-1 therapy.

Try the BMI Calculator →
Dose Phase Duration Typical Weight Change
0.6mg 1 week 0-2 lbs lost
1.2mg 1 week 1-2 lbs lost
1.8mg 1 week 1-3 lbs lost
2.4mg 1 week 2-3 lbs lost
3.0mg (months 2-6) Ongoing 4-8 lbs/month

Over a full year at the 3.0mg target dose, the SCALE trial[1] showed average weight loss of approximately 8 percent of starting body weight, with some patients losing 10 percent or more. liraglutide 1.2mg weight loss average

Should You Track Weight During Week 1?

We recommend taking a baseline weight on the morning of your first injection and then not weighing yourself again until the end of week 1 or even week 2. Daily weighing during the 0.6mg phase can create unnecessary frustration:

  • Normal daily fluctuations of 1 to 3 pounds mask any medication effect
  • Seeing "no change" or slight gains can feel discouraging, even though they're completely normal
  • Early fixation on the scale can set an unhealthy pattern for the rest of treatment

Instead, focus on adapting to the injection routine, managing any side effects, and building the eating and hydration habits that will support your weight loss at higher doses.

Medical References

  1. Pi-Sunyer X, Astrup A, Fujioka K, et al. A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management. N Engl J Med. 2015;373(1):11-22. [PubMed | ClinicalTrials.gov | DOI]

Frequently Asked Questions

Should I be concerned if I don't lose any weight at 0.6mg?
Not at all. Zero weight loss at 0.6mg is the most common outcome and says nothing about how you'll respond at therapeutic doses. The medication needs time and dose to reach its full effect.
I lost 4 pounds in my first week on 0.6mg. Is that normal?
Above-average first-week loss is possible, especially if you also made dietary changes or if you had significant water retention before starting. This early result doesn't necessarily predict faster-than-average long-term results, but it's a positive start.
How does liraglutide 0.6mg weight loss compare to tirzepatide 2.5mg?
Both are introductory doses, but tirzepatide 2.5mg (injected weekly) tends to produce slightly more noticeable appetite suppression than liraglutide 0.6mg (injected daily). At their respective therapeutic doses, tirzepatide produces significantly more weight loss than liraglutide. tirzepatide vs liraglutide
Can I speed up the titration to get to a dose that actually works?
Some prescribers allow faster titration in patients who tolerate 0.6mg very well. But the standard weekly increases exist for good reason. Rushing to 3.0mg increases the risk of severe nausea and vomiting that could cause you to stop the medication entirely. Patience during titration usually pays off with better long-term adherence.

This article is for informational purposes only and doesn't constitute medical advice. Don't judge liraglutide's potential based on the 0.6mg introductory phase.

Contact provider for current pricing Contact provider for current pricing

Talk to a licensed provider

Start your free assessment. A licensed provider reviews every request before anything is prescribed, and not everyone qualifies.

Start the assessment →

Research Snapshot

Provider comparison
Page type
Provider comparison
FormBlends review
Last reviewed
2026-04-01
FormBlends review
FormBlends official source
Official source
Retatrutide evidence source
Official source
Saxenda evidence source
Official source
Semaglutide evidence source
Official source
Tirzepatide evidence source
Official source
Before you act
Check the current prescribing information, regulatory status, and trial source before treating an investigational or newly approved medication as interchangeable with an established therapy.
Check before ordering

Regulatory status, labels, trial records, and sponsor updates can change quickly for obesity-drug pipeline pages. This snapshot is designed to make verification easier, not to replace checking the official source before making a medical or purchase decision. Last page review: 2026-04-01.

Evidence standard

How this page was source-checked

Editorial policy

FormBlends does not claim an individual clinician byline unless a named reviewer is available. For this page, the editorial team checks medical and regulatory claims against primary sources, clinical trials, public datasets, and regulator guidance.

PubMed evidence trail

Research sources used to frame this page

For Liraglutide 0.6mg: Weight Loss Average, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

GLP-1 decision path

Use this page to decide if a provider review is the right next step

Direct answer

Liraglutide 0.6mg: Weight Loss Average research is most useful when it helps you compare eligibility, expected results, side effects, cost, and the supervision needed before treatment.

Evidence check

The strongest GLP-1 pages connect the practical answer to clinical trials, FDA labeling where applicable, and real access constraints.

Safety check

A licensed clinician still needs to review health history, contraindications, current medications, side effects, and dose escalation.

Next step

When the page matches your goal, continue into the FormBlends get-started flow so the intake can route you toward the right prescription review path.

FormBlends Editorial Context

Reviewed May 14, 2026

Average weight loss on liraglutide 0.6mg. Covers realistic expectations at the starting dose, why significant weight loss does not occur at this level, and what to expect as you titrate up. Read "Liraglutide 0.6mg: Weight Loss Average" as a GLP-1 treatment guide where medication choice, dosing, side effects, monitoring, and insurance rules can change the decision. The main job of this page is patient education and clinical context, especially where the topic touches dosing. Because this article has 5 major sections, scan the headings first and then use the FAQ or summary sections to pressure-test the answer. Use it to ask sharper questions of a licensed clinician, not as a substitute for personal medical advice.

  • Confirm whether the page is discussing an FDA-approved use, a compounded option, or research-only context.
  • Ask a licensed clinician how the evidence applies to your health history, medications, labs, and side-effect risk.
  • Check the latest label, trial update, pharmacy policy, or state rule when the article touches medication access.

Original tools and data

Use the FormBlends research stack

These assets are built to be useful beyond a single article: shareable data pages, calculators, provider comparisons, and safety checks that give Google and readers something original to crawl.

Editorial refresh

Practical 2026 note for Liraglutide 0.6mg

Liraglutide 0.6mg now carries extra 2026 context around semaglutide, tirzepatide, retatrutide, cash-pay pricing, safety signals, liraglutide, because those are the subtopics readers tend to compare before they trust a medical or wellness recommendation.

Instead of adding filler, this page keeps the named treatment terms, practical verification points, and next-step questions close to liraglutide 0 6mg weight loss average.

Readers should use the section to check current eligibility, pharmacy or provider policies, and safety questions with a licensed professional before acting.

Liraglutide 0.6mg custom 2026 image for glp-1 weight loss on FormBlends

Custom 2026 image for Liraglutide 0.6mg, glp-1 weight loss, and better treatment decision-making.

Image description: Unique image for this page covering Liraglutide 0.6mg, glp-1 weight loss, safety, cost, provider selection, and patient decision-making.

Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting, stopping, or changing any medication or treatment. FormBlends articles are source-checked against medical and regulatory references, but they are not a substitute for a personal medical consultation.

Written by FormBlends Editorial Research

Prepared by FormBlends Editorial Research. Claims are checked against primary regulatory, trial, label, and public-health sources where available. Reviewed by FormBlends Medical Team for medical accuracy, sourcing, and patient-safety framing.

Ready to get started?

Provider-reviewed GLP-1 and peptide therapy, delivered to your door.

Start Your Consultation

Ready to Start Your Weight Loss Journey?

Get a free medical consultation with a licensed provider. Compounded GLP-1 medications starting at $99/month with free shipping.

Next Best Reads

Free Tools

Provider-informed calculators to support your weight loss journey.